CO66 Survival of Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib in France During 2009-2018: Potentialities and Limitations of Model Adjustment in the SNDS French Hospital and Claim Database
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.145
https://www.valueinhealthjournal.com/article/S1098-3015(22)02349-X/fulltext
Title :
CO66 Survival of Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib in France During 2009-2018: Potentialities and Limitations of Model Adjustment in the SNDS French Hospital and Claim Database
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02349-X&doi=10.1016/j.jval.2022.09.145
First page :
Section Title :
Open access? :
No
Section Order :
11030